Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
he did...sent me a nice little PM too saying he knew who i was etc...lol
Make me look stupid...dare u
you know what...I hope u sold and got shook out at low of day prices
Its not so much inaccurate. Were talking about the people you lead on. Go ahead Ron keep dancing.
you are full of shit. I am one name only and have been for years. Go fuck yourself and give me proof or shit the fuck up
If I were you I would just leave it alone. Its about my mistake by not looking at the filings. I wrote about the R/S but if you get me going your gonna look stupid. Why don't you ask me some interesting questions?
what? I have only one name fool. what's the name of the other person?
I'm not mad about that and I am sure it will have a dead cat bounce between now and May 29th what i'm mad about is your deceiving peps by posting under this screen name while you have that blowhard private thread under another SN. I think we better leave it at that.
sounds like u are mad...relax...this isnt a penny stock like the others u are in ;) These guys are smart, The RS will be less than 8-1 and the OS is being cut in half...Making it more thin and less likely to be taken over when they start making the real $$. Do some research then cry to me later when you make $1000's off this ;)
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=9895399
start at page 29 and read carefully
I dont post on DDXS much anymore is what i meant fyi.
Hey I can afford to go down with the ship. Don't get me started
LMAO !!!!!!You don't post much! Check yourself out PAL
http://investorshub.advfn.com/boards/profilea.aspx?user=206634
Along with your private thread under your other s.n over 100k posts
if u are under water then I would hold on...will just say that
I dont really post all that much anywhere on ihub. I could care less about anyone else either fyi
sure will. Blowhard
i'll be back in though when panic sellers are done ;)...it's a long term play that I flip when they drop it
Yea and being moderator of this thread you warned nobody. Good job. At least I confessed that I wasn't looking DUDE R O N
What do you care you got out! So?????????????????
I knew the day it was filed like everyone else
Your correct however if you were master of DD you would have found out about the R/S on the way here. Your not fooling anyone R O X
page 5...they have owned shares here for a while. Still own shares too. read the filings dude
Baker Bros not here they are on ERBB since January. I guess they are dumping that one though
no shit...u are also the one who tried to sell me the idea of some dumb water company. I am the master of DD
Here its all in Black and white.I am stupid for not checking the filings 2 weeks ago when we were near $1.00
Approving a series of alternate amendments to the Company’s Restated Certificate of Incorporation to effect, at the discretion of the Board of Directors, a reverse stock split of the Company’s common stock, whereby each outstanding 3, 4, 5, 6, 7 or 8 shares would be converted and changed into one share of common stock, and for any such reverse stock split determined by the Board of Directors, a reduction in the number of authorized shares of the Company’s common stock from 100,000,000 to 50,000,000;
I sold also...But I will buy back in before the RS. Baker bros sold out an dropped it fyi.
Smart investors are dumping. They could have avoided this with the proper IR Awareness. May 29th is vote day. Maybe it will have a bounce back before that date,I can only hope!
smart investors would read that closer
No wonder why were tanking R/S being voted on.
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=9895399
Glaxo heart drug that failed trial shows potential benefit
Seems there is quite a bit of mixed opinion on the drug from my twitter feed.
GSK PR
http://us.gsk.com/html/media-news/pressreleases/2014/GSK-presents-data-from-Phase-III-STABILITY-study-of-darapladib.html
http://in.reuters.com/article/2014/03/30/us-heart-glaxosmithkline-idINBREA2T09620140330
and the NEJM article
http://www.nejm.org/doi/full/10.1056/NEJMoa1315878
full PDF
http://www.nejm.org/doi/pdf/10.1056/NEJMoa1315878
BoA comments thanks to @lomu_j
https://twitter.com/lomu_j/status/450256620031713280/photo/1
John Carroll article
http://www.fiercebiotech.com/story/glaxosmithklines-darapladib-team-finds-hope-phiii-bomb/2014-03-30
Thanks, I believe we have a good one here, in time.
Stay tuned.
Hawk
He is still messing with us. I'm telling you that were gonna have a huge short squeeze at some point.
You got that right on the money (no pun intended) lol. Hope you been doing well Hawk!
looks like that seller was holdin this down, looks good today
The Risk/Reward looks very good here right now.
GL all.
Hawk
it's all based on what you are comfortable with. I have done both here
flip play or hold?
this is where i keep my real $$. bank of ddxs. never failed me
GSK had their earnings call today. I didn't catch it yet but there was a Reuters article that mentioned that they hadn't given up on darapladib.
http://www.reuters.com/article/2014/02/05/us-glaxosmithkline-earnings-setbacks-idUSBREA141HY20140205
I see deep blue skies ahead. She is free and clear!!!!!
They are finally allowing her to run today.$1.04 highest its been for awhile. There is no doubt in my mind that it was deliberately being held down in the .77 to 88 range and I am wondering why?
Your right.. It won't stay at these levels forever.
Your G.D Right its oversold. Tremendous consolidation since the dive and some peps are gonna make a fortune.
Followers
|
26
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
419
|
Created
|
12/18/02
|
Type
|
Free
|
Moderators |
diaDexus (DDXS.OB) is a medical diagnostics company, located in South San Francisco, California, focused on the development and commercialization of patent-protected in vitro diagnostic products addressing significant unmet needs in cardiovascular disease.
diaDexus’ first product, the PLAC® Test helps identify individuals at increased risk of suffering a heart attack or stroke, the #1 and #3 causes of death respectively in the U.S. These events can be prevented through early detection and more aggressive risk-reducing strategies.
The PLAC Test measures Lp-PLA2, a vascular-specific inflammatory marker implicated in the formation of rupture-prone plaque, and is the only blood test cleared by the FDA to assess risk for coronary heart disease and ischemic stroke associated with atherosclerosis. There are more than 30 published prospective studies validating Lp-PLA2 as a novel and valuable cardiovascular risk marker that can help improve early risk assessment.
GlaxoSmithKline (GSK) has developed an Lp-PLA2 inhibitor (darapladib) and is currently testing the drug in two large, global, Phase III clinical trials involving over 27,000 patients to determine if inhibition of the enzyme reduces cardiovascular events.
SOUTH SAN FRANCISCO, Calif., Jan. 10, 2011 /PRNewswire/ -- diaDexus, Inc. (OTC Bulletin Board: DDXS), a diagnostics company focused on the development and commercialization of patent-protected in vitro diagnostic products addressing unmet needs in cardiovascular disease, today announced preliminary Q4 2010 revenues of approximately $3.3 million, higher than its prior forecast of $2.8-3.0 million. These preliminary results are unaudited and subject to adjustment prior to the Company filing its Form 10-K on or before March 31, 2011.
The Company also announced a preliminary cash and cash equivalents balance of approximately $20.4 million as of December 31, 2010. This preliminary balance was also higher than the prior Company forecast of $19.7-20.2 million, is unaudited and subject to adjustment prior to the Company filing its Form 10-K on or before March 31, 2011.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |